The largest database of trusted experimental protocols

E2 benzoate

Manufactured by Merck Group
Sourced in Germany, United States, France

E2 benzoate is a laboratory reagent used in various scientific applications. It is a synthetic compound derived from estradiol, a naturally occurring estrogen hormone. The core function of E2 benzoate is to serve as a research tool for the study of estrogenic effects and related biochemical processes. Detailed information about its specific intended uses should be obtained from technical sources or product literature.

Automatically generated - may contain errors

8 protocols using e2 benzoate

1

Standardization of Hops Extract

Check if the same lab product or an alternative is used in the 5 most similar protocols
E2benzoate was purchased from Sigma-Aldrich (Hamburg, Germany). The preparation and standardization (chemical and biological) of the hops extract that was used in the present and other parallel studies has been described in detail previously (Krause et al., 2014 (link); van Breemen et al., 2014 (link)). In brief, hops with an optimum content of prenylated flavonoids were extracted with ethanol under GLP conditions, the bitter acids removed by supercritical CO2 extraction of the dried crude extract, and the resulting spent hops extract processed to yield a dry, yellow powder (Hopsteiner, New York, NY, USA). Details of the LC-MS chemical standardization of this bulk spent hops extract for four marker compounds (XN, IX, 8PN, 6PN) have been reported using LC-MS (Krause et al., 2014 (link)) as well as by UHPLC and qHNMR (Ramos Alvarenga et al., 2014 (link)) as part of the development of hops extracts from this bulk extract. The material was stored at −25 °C until use and has shown no detectable signs of degradation over time.
+ Open protocol
+ Expand
2

Ovariectomized Rat Sexual Receptivity Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wistar female rats without sexual experience were used for this study. They were bilaterally ovariectomized (OVX) under anesthesia with a mixture of ketamine (95 mg/kg) and xylazine (12 mg/kg). Two weeks later and to induce sexual receptivity, OVX females received a subcutaneous (sc) injection of E2 benzoate (25 μg/rat; Sigma St. Louis, Missouri, USA) and progesterone (1 mg/rat; Sigma), 48 and 4 hours respectively, before the behavioral test. These doses were used to induced high levels of sexual receptivity and we have used them repeatedly before [33 (link), 34 ]. For Sexual behavior tests, sexually experienced males were used as stimulus. Experiments were approved by the Instituto de Neurobiología Animal Care Committee which follows NIH guidelines for the use and care of animals.
+ Open protocol
+ Expand
3

Mating Behavior Across Generations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tests were performed in a dark room under red light. Naive males were individually housed for one week before the first test in a room devoid of the presence of any females. Each male of the F1, F2, F3 and F4 generations (n = 12–14 for each group of each generation obtained from 3 to 5 different litters per group) was tested three times, corresponding to the three trials, with a time interval of two weeks between trials. Males were tested in a cage containing fresh litter. After 10 min habituation an estrous female was introduced and the test lasted for 30 minutes. A mount involved a male placing its two anterior paws on either sides of the flank of the receptive female. Intromission was determined when the male carried out back and forth thrusting movements of the pelvic region. The numbers of ano-genital investigations and mount attempts, the latencies and the frequencies of mounts and intromissions were scored41 (link).
Estrous females used as stimuli were ovariectomized under general anesthesia (xylazine/ketamine) and implanted with Silastic implants (Dow Corning) containing 50 μg of E2-benzoate (Sigma-Aldrich). Four hours before the tests, females were given a subcutaneous injection of 1 mg of progesterone (Sigma-Aldrich) diluted in 100 μL of oil to induce receptivity.
+ Open protocol
+ Expand
4

Ovariectomized Rat Estrogen Priming

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male gonads were left intact and all females were subjected to OVX at least 7 d before each experiment. Rimadyl (4–5 mg/kg, s.c.) was given immediately after surgery for relief of postoperative pain. Females received either an injection of sesame oil (50 μl, s.c.; Sigma-Aldrich) or a priming dose (0.125 μg/50 μl sesame oil, s.c.) of E2 benzoate (Sigma-Aldrich) on the Friday morning following surgery. In addition, oil or a low (0.25 μg) and then a high (1.5 μg) dose of E2 benzoate was administered in the morning of the 2 d preceding experiments. Circulating levels of E2 were verified by the uterine weights (<25 mg for OVX and >95 mg for E2 treated) at the time of hypothalamic slice preparation (between 8:30 and 10:30 A.M.).
+ Open protocol
+ Expand
5

Olanzapine Depot Effects in Ovariectomized Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two weeks after sham surgery or OVX, rats (n=9 in each treatment group) received one intramuscular injection of either OLZ pamoate depot formulation (100 mg/kg; ZypAdhera, Eli Lilly) or vehicle (VEH) solution (injection volume 160 µL/250 g body weight) (Skrede et al., 2014 (link)). A subgroup of the OVX rats (n=8) received daily s.c. injections of E2 (E2 benzoate; standard dose of 2 μg dissolved in 100 μL of sesame oil; both from Sigma) or vehicle (100 μL of sesame oil; control rats). In the ICV experiment, vehicle (5 μL of saline containing 10% of dimethyl sulfoxide) or E2 (17β-estradiol, 5 nmol dissolved in 5 μL of vehicle) was administered through the inserted cannulae at 8 am and 8 pm for 7 days (n=9–10 in each treatment group). At 24 hours after the first ICV E2 dose, animals received a single intramuscular dose of OLZ pamoate 100 mg/kg. Animals and chow were weighed daily. Rats treated with SC E2 were sacrificed after 8 days of treatment, that is, on day 22 after surgical procedures (OVX or sham). Tissue and blood samples were harvested and stored at -80°C until further analysis. Due to limited durability of ICV cannulas, rats treated with ICV E2 were killed after 6 days of treatment, that is, on day 20 after OVX or sham surgery.
+ Open protocol
+ Expand
6

Sexual Behavior and Preference in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
All sexual behavioral experiments were performed during the dark phase of the dark/light cycle, 1 hour after lights off. Tests were filmed with an infra-red light in a dark room. Two weeks before W0, male mice were placed for a week with a receptive female (in oestrus phase) to gain sexual experience. At W4, males were tested in an open field (50 x 50 cm) with a receptive female for 30 minutes. Females were ovariectomized and implanted with Silastic implants (Dow Corning, Saint Denis, France) containing 50 μg of E2-benzoate (Sigma-Aldrich). Four hours before the tests, females were given a subcutaneous injection of 1 mg of progesterone (Sigma-Aldrich, P6149, St. Quentin Fallavier, France) diluted in 100 μL of oil to induce receptivity (36 (link)). The latencies and frequencies of mounts and intromissions were recorded. The sexual preference of males was also evaluated. Males were placed in the centre of a three-compartment chamber separated by Plexiglas with an opening at the base permitting olfactory and visual contact. Following a 10 min period of habituation, a receptive female (detected by a vaginal smear) and an unfamiliar male were each placed in one of the side compartments of the chamber. The time spent by the tested male mouse near each compartment was recorded for 10 min.
+ Open protocol
+ Expand
7

Hormone Administration via Peanut Butter

Check if the same lab product or an alternative is used in the 5 most similar protocols
E2, E2 benzoate (EB), and P4 (Sigma-Aldrich; St. Louis, MO) were independently dissolved in ethanol prior to dissolution in sesame oil (Sigma-Aldrich) at a concentration of 600 μg/ml (E2 or EB) and 15 mg/ml (P4). Equivalent volumes of ethanol without hormone were added to sesame oil to serve as the vehicle control for each hormone. Body weights were obtained prior to feeding each day and used to determine the appropriate volume of hormone to administer to each animal. Each day the appropriate volume of hormone or vehicle was mixed into approximately 4 g of peanut butter (Skippy Natural Peanut Butter) placed on 2x2 inch squares of parchment paper. Each animal was offered two allotments of peanut butter to achieve the appropriate treatment combination e.g. E2 and vehicle, P4 and vehicle, E2 and P4, or vehicle and vehicle. The animals had access to the treatment until the next day when old papers were removed and new treatments were given. Hormone consumption was evaluated each morning before administering new treatments based on visualization of whether the paper was completely devoid of peanut butter (all), peanut butter was partially consumed (partial), or appeared the same as it had when hormones were introduced the previous day (none).
+ Open protocol
+ Expand
8

Ovariectomy and Estrogen Replacement in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
For ovariectomy (OVX), rats were anesthetized with ketamine (64 mg/kg, i.p.; Fort Dodge Laboratories, Fort Dodge, IA) and xylazine (5.3 mg/kg, i.p.). Under aseptic conditions, both ovaries were externalized and excised. Muscle and skin layers were individually closed. Six days later, rats received a single s.c. injection of 10 μg/kg E2 benzoate (Sigma, E-9000) at 10 μg/mL, or an equivalent volume of vehicle (10% ethanol/90% corn oil). By this time point after OVX, serum E2 levels were shown to be below non-proestrus levels by a previous study [33 (link)]; this dose of E2 was chosen to mimic the surge in E2 observed during proestrus in rats [23 (link), 24 (link), 34 (link)–36 (link)] as previously described [23 (link), 24 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!